Introduction
============

Contradictory results have been reported on the relationship between orthostatic hypotension (OH) and cognitive impairment. The large Atherosclerosis Risk in Communities Study (ARIC) reported no association between cognitive performance and OH, adjusted for cardiovascular risk factors after a 6-year follow-up, similar to clinical studies on hypotensive syndromes in geriatric patients.[@b1-cia-9-1993],[@b2-cia-9-1993] Increased prevalence of OH was reported in a clinical study of subjects suffering from dementia,[@b3-cia-9-1993] and elderly subjects attending memory clinics showed an association between impaired cognitive function and OH, emphasizing the need for longitudinal studies to investigate the nature of this association.[@b4-cia-9-1993] A 5-year longitudinal study in otherwise healthy elderly women reported low beta activity on electroencephalography 5 years later among those with OH in contrast to women without OH who remained dementia-free.[@b5-cia-9-1993] A recent review by Perlmuter et al pointed out that few studies have specifically examined the effects of subclinical OH.[@b6-cia-9-1993]

Several factors might influence the incoherent findings between OH and cognitive decline.

Clinical OH is defined as a 20 or 10 mmHg drop in systolic or diastolic peripheral blood pressure after rising from a supine to an upright position. Subclinical OH (orthostatic intolerance OI) 6 is defined as a systolic drop \<20 mmHg or diastolic drop \<10 mmHg with a variety of orthostatic symptoms, like dizziness, fatigue, and lightheadedness as a result of deteriorated cerebral autoregulation.[@b7-cia-9-1993] Thus, changes in cerebral autoregu lation at levels below the present OH definitions of peripheral blood pressure drop might induce OI, which has not been taken into account in studies using the present OH definition.

Another factor could be the modifying effect of hypertension. Hypertension is a risk factor for OH due to arterial stiffening, which, in turn, reduces the ability of cerebral autoregulation to compensate for blood pressure variation.[@b8-cia-9-1993] When this ability declines, the intracerebral vessels are more unprotected from sudden lowering or rising of blood pressure, which are associated with disruptions in neurovascular coupling that could lead to cognitive decline.[@b8-cia-9-1993] Further, hypotension has been recognized as a risk factor for cognitive decline or dementia, especially in subjects with OH, since their blood pressure might fall below limits of autoregulation during orthostatic drops.[@b9-cia-9-1993],[@b10-cia-9-1993] Whether low blood pressure is a consequence or cause of incipient dementia is a question that remains to be solved.[@b11-cia-9-1993] Furthermore, age-related changes in circadian rhythm with low blood pressure during the night and also dipping at night has been associated with lower cerebral blood flow and cognitive impairment.[@b12-cia-9-1993]

The concept of mild cognitive impairment (MCI) can be categorized into amnestic MCI (aMCI) and non-amnestic (single or multidomain) MCI (naMCI), depending on the cognitive domains affected.[@b13-cia-9-1993] Asymptomatic OH has been correlated with cognitive decline and memory complaints among diabetes mellitus patients and associated with cardiovascular risk factors;[@b6-cia-9-1993] however, few, if any, studies have examined the effect of symptomatic subclinical OH on cognition. Cognitive decline associated with OH most likely reflects the effect of impaired cerebral perfusion on end artery-supplied areas such as the hippocampus, which is known to play an important role in both short- and long-term memory and spatial ability. Decline in hippocampal size is known to predict conversion from MCI to dementia.[@b14-cia-9-1993] In this study, we have chosen three-word recollection from the Mini-Mental State Examination (MMSE)[@b15-cia-9-1993] as an indicator of memory and learning ability. MCI in this study could therefore be referred to as aMCI. OH is common in the elderly population. The prevalence of OH increases from about 15% to 30% in those aged 60 to 90 years of age and could be a contributory factor for MCI.[@b7-cia-9-1993]

Recent studies have indicated changes in incidence and prevalence of MCI and dementia. The Rotterdam Study reported decreased mortality from 1990 to 2000, but also a decreasing incidence of dementia, from 31 to 26 per 1,000 person-years (py), in the age range 80 to 89 years.[@b16-cia-9-1993] A Swedish study with a follow-up of the Kungsholmen cohort noted constant dementia prevalence and reduced mortality, indicating a lower incidence.[@b17-cia-9-1993] The US Health Retirement Study 1993--2002 reported a marginal reduction in MCI prevalence, which was partly explained by better education.[@b18-cia-9-1993] These findings call for further longitudinal studies to compare whether changes in incidence of MCI and dementia in the general elderly population are taking place.

The aims of this study were to describe the incidence of MCI and dementia and, secondly, to explore relationships between OH and orthostatic symptoms (OI) and the risk of cognitive decline in a longitudinal 6-year follow-up study among the general elderly population.

Methods
=======

This was a prospective cohort study based on data from the longitudinal general population study Good Aging in Skåne (GÅS-SNAC), part of the Swedish National Study on Aging and Care.[@b19-cia-9-1993],[@b20-cia-9-1993] The GÅS-SNAC population, which comprised 2,931 men and women (44%/56%, respectively) from nine age cohorts -- 60, 66, 72, 78, 81, 84, 87, 90, and 93 years of age -- was randomized from five urban and rural municipalities and invited to participate by letter using the National Municipality Registry. Baseline examination was conducted between February 2001 and July 2004, with a participation rate of 60%. At follow-up 6 years later (2007--2010) (participation rate: 82% of survivors), 1,832 participants were reexamined, with 1,099 subjects lost to follow-up (710 deceased, nine moved out of county, and 380 nonparticipants). All subjects gave their informed consent prior to taking part in the study.

Exclusion criteria were the following conditions at baseline: MMSE score \<24;[@b15-cia-9-1993] MCI or dementia (definitions below); previous stroke; myocardial infarction or angina pectoris; and inability to perform an OH test. An additional 23 participants with incomplete cognitive tests at baseline or follow-up examination were excluded, leaving a total of 1,480 participants fulfilling the study criteria.

Dementia was defined according to the *Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition* (DSM-IV) criteria,[@b21-cia-9-1993] based on clinical examination, medical records, and proxy information from spouses/relatives and ward staff. The categorization of all other diseases was based on the International Statistical Classification of Diseases and Related Health Problems (ICD)-10 after medical examination.[@b22-cia-9-1993] Stroke included cerebral infarction, hemorrhage, and transient ischemic attack. The project physician had access to all inpatient medical records from the National Medical database covering all hospitals in southern Sweden. Outpatient medical records were retrieved from general practitioners. Inpatient medical diagnoses were also retrieved from the Swedish National Inpatient Register covering all visits in Sweden until 1987 using the specific and individual Swedish civic number. Medication was categorized according to the Anatomical Therapeutic Chemical classification.[@b23-cia-9-1993] Antihypertensive medication referred to current medication.

MCI was defined as the combination of cognitive complaint and cognitive decline evident from objective cognitive tasks in the absence of dementia.[@b24-cia-9-1993] Cognitive complaint was assessed by the common self-reported scale by Crook et al, which contains six 5-graded questions on memory functioning in daily functioning and the and the sum scores range from 7 to 35.[@b25-cia-9-1993] The age-adjusted cut-off limit was set to the mean +1 standard deviation limit corresponded to a score of 28. Cognitive decline was defined as a score of 0 or 1 on the MMSE three-word later recall test.[@b15-cia-9-1993] Since memory domain was the criteria for cognitive decline, our definition of MCI could be referred to as aMCI. Dementia or an MMSE score below 24 at follow-up were not included in MCI. Impaired activities of daily living (ADL) was not considered an exclusion criterion. However, 88% were independent in instrumental ADL, including shopping, transportation, cooking, and cleaning (definition below), and 86% were independent in personal ADL, including six activity functions: mobility, dressing, eating, bowel function, bladder function, and bathing.

Subjective memory loss was defined as a score of \>28 on the Crook scale in the absence of objective memory loss, dementia, or an MMSE score below 24. Objective memory loss was defined as a score of 0 or 1 on the MMSE three-word later recall test in the absence of subjective memory loss, dementia, or an MMSE score below 24. Thus, at follow-up, the MCI, dementia, subjective memory loss, objective memory loss, and control groups were mutually exclusive.

The study procedures included the same study protocol at baseline and follow-up, including a comprehensive medical examination by a physician with detailed medical history, diagnoses, medication, assessments of physical and cognitive tests by trained registered nurses, and self-reported questionnaires. Information was requested regarding cognition and ADL performance from spouses and from ward staff for participants in sheltered living. Visits at home or in sheltered living were offered if the participant was unable to come to the research center. Descriptive data of the population are presented in [Table 1](#t1-cia-9-1993){ref-type="table"}.

Hypertension was defined as \>140/90 mmHg or current antihypertensive drug treatment. Systolic (SBP) and diastolic blood pressure (DBP) were measured to the nearest 2 mmHg with an appropriate size-adjusted cuff around the right arm (with the subject in a sitting position) three consecutive times using a mercury sphygmomanometer, and a mean blood pressure value was calculated.

For the OH test, participants rested in the supine position for 10 minutes before starting the test. Blood pressure and pulse were assessed immediately after the rise from the supine to a standing position and after 1, 3, 5, and 10 minutes of standing without external help. OH was defined as a fall in SBP of greater than 20 mmHg and/or a fall in DBP of greater than 10 mmHg after 1 to 10 minutes' standing and a fall in DBP of greater than 40 and 20 mmHg SBP/DBP immediately upon standing up. Recovery of SBP was defined as the quotient of the highest recorded SBP after the stand and SBP at rest. Maximal SBP and DBP fall during the 10-minute stand was defined as the difference between baseline and the lowest value after the stand. Participants were asked whether they experienced symptoms of autonomic failure associated with OH during the test and about occurrence of the same symptoms during the preceding 12 months when rising to a standing position according to a predefined protocol of listed signs and symptoms. The following 12 signs and symptoms of OI in relation to standing were asked about: dizziness, fatigue, blackouts, nausea, instability, ringing in the ears, vertigo, lightheadedness, headache, syncope, confusion, and sweating. Subjects reporting any of these symptoms in the preceding year were categorized as "previous OI" and those who experienced symptoms or signs during the OH test were categorized as "present OI".

Subjects were categorized according to their smoking habits as present smokers (regular/occasional smoking), former smokers, and nonsmokers. Physical activity was divided into two categories, with low-to-medium activity referring to a sedentary lifestyle or light activity for 2--4 hours weekly, and high activity referring to gardening, running, or other strenuous activities for ≥3 hours weekly. Marital and cohabitation statuses were categorized as either living alone or living in a relationship. Education was categorized in four groups: elementary school, secondary school, high school, and university level.

Diabetes was defined as either diabetes mellitus type 1 or type 2 according to ICD-10 and based on information from medical records. ADL was assessed through self-report according to Åsberg and Sonn's revised ADL scale, which assesses four instrumental ADL (cleaning, grocery shopping, transportation, and cooking) and six activities of personal daily living, including bathing, mobility, and eating.[@b26-cia-9-1993] Independence in ADL was defined as independence in instrumental ADL and activities of personal daily living.[@b26-cia-9-1993] Depressive mood was assessed by means of the Comprehensive Psychopathological Rating Scale (CPRS), part of the Montgomery--Åsberg Depression Rating Scale (MADRS) comprising 20 items scored from 1 to 60 with a score of \>20 indicating depressive mood.[@b27-cia-9-1993]

SPSS version 20 was used for statistical analysis. Presence of OH at baseline was related to the risk of incident dementia, MCI, only subjective memory complaints, or only objective memory loss at 6-year follow-up and expressed as odds ratios (ORs) with 95% confidence intervals (CIs) in separate logistic regression analyses adjusted for age and education. The same analyses were performed stratified for hypertension or antihypertensive drug treatment. A linear regression model, adjusted for age (data not shown) analyzed the relationship between MCI and maximal blood pressure fall. Seventeen participants lacked information on resting blood pressure in the OH test and the mean value of three sitting blood pressure assessments were imputed. The chi-square test was used to test differences in proportion between the groups. The rationale for excluding stroke and cardiovascular conditions at baseline was that both are potential confounding factors that could introduce false risk associations.

The Regional Ethics Committee at Lund University, Lund, Sweden approved the study. All subjects provided written consent for participation in the study.

Results
=======

The mean age of the study sample was 68 (standard deviation 8.5) years. The sample comprised 44% men and 56% women, and 53% of all participants presented some degree of cognitive deficit at the 6-year follow-up ([Table 1](#t1-cia-9-1993){ref-type="table"}).

The incidence of MCI during the 6-year follow-up was 8% of the total study population, or 14.2/1,000 py ([Table 2](#t2-cia-9-1993){ref-type="table"}), distributed among age groups as follows: 12.1/1,000 py and 6.9/1,000 py for men and women aged 60 to 69 years, respectively, to 40.5/1,000 py for men and 16.9/1,000 py for women aged \>80 years.

The incidence of dementia was 8% (13.9/1,000 py), distributed as 5.7/1,000 py and 6.2/1,000 py for men and women aged 60 to 69 years, respectively, and increasing to 38.2/1,000 py for men and 46.2/1,000 py for women aged \>80 years. The occurrence of any type of cognitive impairment during this 6-year period was 90.2/1,000 py. The group with incident dementia had a higher proportion of hypertension/treatment for hypertension (73%) at baseline compared to controls (60%).

The proportion of OH was 18% in the total sample, with 16% among controls compared to 24% in the MCI group (*P*=0.413) and 31% in the dementia group (*P*=0.008; OR =1.93 \[95% CI: 1.19--3.14\]) after age adjustments. The prevalence of OH was 14% among those aged 60 to 69 years, 23% among those aged 70 to 79 years, and 28% among subjects \>80 years in the total study population.

[Table 3](#t3-cia-9-1993){ref-type="table"} presents the relationship between systolic or diastolic OH at baseline and MCI and dementia 6 years later (OR =1.59 \[95% CI: 1.00--2.50\] and OR =2.49 \[95% CI: 1.62--3.82\], respectively). Participants with OI, irrespective of OH drops in blood pressure during OH testing, had higher age-adjusted risk for incident MCI 6 years later (OR =2.07 \[95% CI: 1.39--3.08\]) and also higher age-adjusted risk for subjective memory loss (OR =1.55 \[95% CI: 1.07--2.25\]).

Of those 283 participants with OH, the proportion of OH occurring only during the last 10 minutes of testing was 3.2% for diastolic OH (3/94) and 6.9% (17/247) for systolic OH, and, overall, 5.9% of all the 283 identified OH cases was captured only at the 10-minute assessment. The significant relationship between previous and present OI and MCI was OR =1.84 (95% CI: 1.20--2.80) and the relationship between previous and present OI and subjective memory loss was OR =1.50 (95% CI: 1.02--2.20). The corresponding association between only previous OI and MCI was OR =2.12 (95% CI: 1.38--3.26) and, between OI and subjective memory loss, OR =1.54 (95% CI: 1.04--2.28).

Age-adjusted ordinal regression analyses stratified for hypertension or hypertensive drug treatment showed the same significant pattern for OI at baseline as a predictor for developing MCI 6 years later independently of hypertension or treatment for hypertension. In the non-hypertensive group, the age-adjusted OR for present or previous OI at baseline and risk for incident MCI at 6-year follow-up, irrespective of blood pressure fall, was 1.71 (95% CI: 1.10--2.31), compared to OR =1.76 (95% CI: 1.11--2.13) for the hypertensive group. The corresponding OR for previous OI only and MCI was 1.79 (95% CI: 1.18--2.41) in the non-hypertensive group, compared to 2.00 (95% CI: 1.40--2.61) for the hypertensive group. No associations were noted for incident dementia and OI after stratification for hypertension.

The combination of hypertension at baseline and incident MCI respectively incident dementia was associated to a higher proportion of OH. Either systolic or diastolic OH during the test were noted in 37% of hypertensive incident MCI and 42% incident dementia cases. Corresponding proportions of OH in the non-hypertensive groups of MCI and dementia were 9% and 22%. Recovery of SBP and changes of pulse during the OH test were not related to cognitive impairment or dementia (data not shown). Independence in ADL, such as shopping, transportation, cooking, or handling cleaning of their own house, was reported at baseline by 90% of the control group compared to 88% for the incident MCI group and 69% of the incident dementia group. Forty-two subjects had a CPRS score \>11, indicating depressive mood at follow-up and distributed as follows: 15 subjects in the control group, eight in the group with objective memory loss, seven in the dementia group, six in the group with subjective memory loss, and six in the MCI group. Differences were not significant between groups. The proportions of those with diabetes and hypertension did not differ between the MCI and control groups, but were significantly higher among the dementia group than the controls ([Table 1](#t1-cia-9-1993){ref-type="table"}).

Discussion
==========

The incidence of MCI in this cohort of the elderly general population investigated between 2001 and 2010 was 14.2/1,000 py during a 6-year period (baseline took three years to perform during the years 2001 to 2004; the 6-year follow-up was performed during 2007 to 2010) increasing from 12.1 to 40.5 per 1,000 py among men and from 6.9 to 16.9 per 1,000 py among women from 60 to 90 years of age. Another finding was that OH is related to the development of dementia and cognitive decline, and that OI with symptoms of OH, irrespective of drop in blood pressure, is related to incidence of MCI and subjective memory loss after adjustment for age and education. The incidence of objective memory loss seems to decline with age, but this is explained by a migration from this group to the MCI or dementia groups, in which the incidence rates increased with age.

Previous cross-sectional studies have reported an association between OH and cognitive decline.[@b4-cia-9-1993],[@b6-cia-9-1993],[@b12-cia-9-1993],[@b28-cia-9-1993] A longitudinal study on OH and development of electroencephalography changes in previously healthy women indicated causality between OH and reduced cerebral blood flow, which in turn could lead to cerebral damage.[@b5-cia-9-1993] To our knowledge, this is the first study showing the relationships between OI and incident MCI and between OI and subjective memory loss as possible early indicators of cerebral damage, without fulfilling the OH blood pressure criteria. The cause of OI is unknown, but may be related to abnormalities in the autonomic regulation of cardiovascular function. The cognitive decline suggests a deterioration of cerebral autoregulation over time. Several possible physiological mechanisms could explain the association between blood pressure regulation and cognition. Collins et al found that parasympathetic dysfunction was more than five times more common among subjects with MCI compared to controls.[@b29-cia-9-1993] They presented the hypothesis that this may be explained by early neuroanatomical and neurochemical changes caused by Alzheimer's disease. This may accelerate cognitive decline via proinflammatory mechanisms and/or hypotension-induced cerebral hypoperfusion.[@b29-cia-9-1993] This would support that the findings related to aMCI are more sensitive predictors of early Alzheimer's disease than those of naMCI.

Another plausible cause could be age-related increased cerebral susceptibility to OH and blood pressure drops in parallel with a higher proportion of elderly subjects on antihypertensive drug treatment. Circadian blood pressure rhythms diminish with age as well as the normal nocturnal dipping noted in middle age. Nocturnal dipping is a normal finding in middle age but instead at high ages it has turned out to be risk factor for cognitive decline defined by cerebral blood flow and cognitive tests in longitudinal studies of subjects aged 80 years and above.[@b12-cia-9-1993],[@b30-cia-9-1993] This phenomenon is most likely related to prolonged periods of cerebral hypoxia.[@b30-cia-9-1993] A previous study reported that SBP but not DBP changes during a stand test was related to OI, supporting findings from this study.[@b31-cia-9-1993] This finding is in line with studies showing that SBP but not DBP changes (decline) during tilting correlate with reduced white matter cerebral blood flow in anterior and posterior brain regions among OH patients.[@b32-cia-9-1993] Whereas DBP tends to drop with increasing age, SBP continues to increase with age regardless of the initial level in early to middle adulthood. The long-term impact of elevated midlife SBP on reduced cognitive performance has been reported in longitudinal studies.[@b33-cia-9-1993],[@b34-cia-9-1993]

We have previously reported that cerebral blood flow in white matter is correlated with SBP, in contrast with DBP, and that SBP was lower among subjects with dementia compared to controls.[@b35-cia-9-1993] This study shows an age-adjusted risk of orthostatic symtpoms in realtion to incident MCI and subjective memeory loss independent of peripheral blood pressure using regular brachial sphygmomanometers. These findings raise some questions concerning methods and definition of OH. In this study, assessment of peripheral blood pressure after tilting to standing position was assessed in minute intervals. It is possible that continuous assessment might have detected a rapid blood pressure drop that occurred between the assessments. We chose to measure blood pressure at 1, 3, 5, and 10 minutes after changing from a supine to an upright position during the OH test. This is a longer time frame than in many other studies.[@b36-cia-9-1993] The most common method is to measure blood pressure at 1 and 3 minutes, and sometimes also at 5 minutes. Of the 283 cases with OH in this study, 5.9% occurred only after 10 minutes. We might have captured more subjects with OH than other studies, even though our incidence numbers are similar to previous reports from the general population.[@b4-cia-9-1993],[@b11-cia-9-1993],[@b37-cia-9-1993],[@b38-cia-9-1993] However, symptomatic symptoms can occur after 5 minutes, depending on autonomic response and those being characterized as non-orthostatic in other studies. Any misread of blood pressure by the physician would merely introduce a non-differential misclassification. Finally, the group of people that suffers from the symptoms of OH seems to be at risk of developing cognitive deficiencies, despite the fact that they do not qualify for OH. A fall of greater than 20 mmHg in SBP or greater than 10 mmHg in DBP might therefore be questioned when analyzing associations to cognitive decline, since they could introduce misclassification for subjects with less blood pressure fall using peripheral (brachial) blood pressure for screening of OH. In this study, the guidelines used for initial OH were according to the European Society of Cardiology.[@b39-cia-9-1993] The rationale for higher cut-off levels to define OH immediately after standing up, ie, falls of \>40 mmHg for SBP and \>20 mmHg for DBP, is the rapid hemodynamic changes of vascular resistance, heart rate, and rebound effects during the first half-minute.[@b40-cia-9-1993] However, the noted increase of OH after about 75 years of age might be explained by atherosclerotic changes and autonomic dysfunction. On the other hand, it could be speculated on the need of age-related cut-off limits of OH to reduce possible detection bias.

In this study, we chose three-word recollection from the MMSE[@b15-cia-9-1993] as an indicator of memory and learning, and aMCI. In an extensive review, Tombaugh and McIntyre reported moderate-to-high test--retest reliability, citing correlations of 0.38 to 0.99 in studies of MMSE, and corresponding values for internal consistency as expressed by Cronbach's alpha coefficients in the order of 0.54 to 0.96. Studies on concurrent validity have reported correlation coefficients ranging from 0.70 to 0.90 between MMSE and other measures of cognitive impairment.[@b41-cia-9-1993] The sensitivity of the three-word recall was reported to be 0.65 and the specificity 0.85 by Kuslansky et al.[@b42-cia-9-1993] aMCI has been associated with progression to Alzheimer's disease, and it could be argued that the lack of association with SBP or DBP falls in this study might have been captured by assessing other cognitive domains and naMCI associated with vascular dementia and normal aging.[@b38-cia-9-1993] We intend to explore this approach in forthcoming analyses. Classification of subtypes of dementia would have increased understanding of possible pathological mechanisms behind our findings. The aMCI criteria according to Petersen et al include largely intact ADL.[@b24-cia-9-1993] In this study, subjects with disabilities and impaired ADL were not excluded, but very few subjects had impaired ADL of personal functions, and no differences regarding ADL were noted between groups. Thus, it is not likely that this would have influenced the noted associaitons between OH reactions and reported incidence of MCI. Furthermore, subjects with an MMSE score below 24 at baseline were excluded in order to reduce the possibility of including subjects with dementia. The exclusion of subjects with stroke and cardiovascular disease at baseline might introduce some underestimation of incident MCI, since this group has a higher load of vascular risk factors. On the other hand, both these conditions are possible confounding factors that can affect both cognition and the risk for OH, which could introduce false risk associations despite the longitudinal design. Education and age are well-known confounders for MCI and were controlled for in analyses.

As expected, hypertension or treatment for hypertension was related to a higher proportion of OH, and the proportion of OH in incident cases of MCI and dementia was almost double compared to non-hypertensive subjects. However, the association of orthostatic symptoms to MCI, irrespective of blood pressure fall, remained in the non-hypertensive group, indicating that insufficient cerebral autoregulation is not only mediated through hypertension-induced atherosclerosis or antihypertensive drug adverse events with peripheral hypotension.[@b9-cia-9-1993]

A previous review on MCI by Ward et al in 2012 reported 13 studies, but only five studies presented age-stratified rates.[@b43-cia-9-1993] Two of these studies[@b44-cia-9-1993],[@b45-cia-9-1993] observed significant increases of MCI with age, from 3.7 to 46.6 per 1,000 py and from 5.3 to 16.3 per 1,000 py, respectively, in those aged 65 to 85 years of age. Different operational definitions of diagnostic criteria might explain the differences in published estimates of MCI. Furthermore, the study by Solfrizzi et al in some cases applied the criteria of subjective memory complaints retroactively, since the study did not require subjective memory impairment.[@b44-cia-9-1993] Another systematic review of incident MCI identified nine studies in which incidence of aMCI subtypes ranged between 9.9 and 40.6 per 1,000 py, which was similar to our findings.[@b46-cia-9-1993] The incidence of naMCI subtypes ranged from 28 to 36.3 per 1,000 py, but no age-stratified data were presented.[@b46-cia-9-1993] Roberts et al estimated the incidence of aMCI in men and women separately and found a higher incidence for men (43.9/1,000 py) than for women (33.3/1,000 py),[@b13-cia-9-1993] which was also a finding of the present study. The difference between men and women in incidence rate of MCI declined with higher education, but a difference was observed regardless of whether the length of education was more or less than 12 years. These reported incidence studies represent only a part of all cognitive deficits categorized as MCI. To summarize, this study and previous similar studies do not support the finding that age-adjusted MCI incidence decreases, although the birth cohort effects of higher education should be taken account in forthcoming longitudinal studies.[@b18-cia-9-1993]

Our data on incidence of dementia for the age groups 60 to 69 and 70 to 79 years are higher than those of a recent study from Rotterdam, the Netherlands that indicated a decreasing incidence over the preceding decade.[@b16-cia-9-1993] However, our data are comparable to those of a study by Letenneur et al which comprised similar age groups and reported an overall incidence of dementia of 16.3/1,000 py, compared to 13.9/1,000 py in the present study.[@b47-cia-9-1993]

This is, to our knowledge, the first longitudinal study on the relationships between OH, orthostatic symptoms, and the development of MCI. The same standardized protocol was used at baseline and at follow-up, and the study population was randomized from the general population and not restricted to any disorder, sex, ethnicity, or education, which increases generalization. Home visits were offered to those unable to attend the research center to reduce selection bias of more frail subjects. A higher proportion of disabled subjects among nonparticipants cannot be ruled out, but the 6-year-long follow-up would have reduced the effects of this on incidence estimates. We have no reason to believe that depressive mood at follow-up confounded the results.

Conclusion
==========

OH and symptoms of OH in the elderly general population seem to be risk factors for cerebral hypoxic damage and incident MCI, probably due to disturbed cerebral autoregulation. This should be considered in medical treatment, especially that of blood pressure.
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###### 

Baseline descriptive statistics of mean values and proportions of OH test parameters and background factors for controls and participants with MCI, dementia, and objective and subjective memory loss at 6-year follow-up of the general elderly Swedish population of GÅS-SNAC (n=1,480)

                                                               Controls   Objective memory loss   Subjective memory loss   MCI       Dementia   All participants
  ------------------------------------------------------------ ---------- ----------------------- ------------------------ --------- ---------- ------------------
  Participants (n/%)                                           697/47     381/26                  158/11                   123/8     121/8      1,480/100
  Valid OH test                                                686        375                     156                      123       119        1,459
  Men/women (%)                                                44/56      53/47                   32/68                    52/48     42/58      46/54
  Age (years)                                                  65.6       67.6                    70.1                     71.7      76.2       68.0
  High school/university (%)                                   32/29      27/18                   17/24                    24/15     27/12      29/23
  Hypertensive (\>140/90) or antihypertensive treatment (%)    60         67                      65                       67        73         64
  Hypertensive at baseline (mean of 3 BP) (%)                  55         61                      56                       59        68         59
  Antihypertensive treatment (%)                               21         24                      27                       25        33         23
  Diabetes type 1/2 (%)                                        0.3/4.6    0.5/5.8                 0/4.4                    0.8/4.9   1.7/10.7   0.5/5.4
  Treatment for hyperlipidemia (%)                             13         18                      16                       15        15         15
  Physical inactivity (%)                                      11         12                      11                       17        25         13
  Present smoker (%)                                           13         17                      11                       8         15         13
  Past or present smoker (%)                                   62         57                      60                       50        49         58
  Born abroad (%)                                              9          7                       9                        9         10         9
  Single or living alone (%)                                   28         35                      50                       30        45         30
  SBP resting (mmHg) (mean; SD)                                142; 19    146; 21                 144; 21                  149; 21   149; 20    146; 22
  DBP resting (mmHg) (mean; SD)                                82; 9.2    82; 9.7                 80; 10.5                 81; 9.8   79; 10.0   83; 10.6
  Heart rate resting (mean; SD)                                67; 11     66; 10                  68; 10                   66; 13    68; 11     67; 11
  Max difference SBP supine -- upright 10 minutes (mean; SD)   10; 11     11; 10                  11; 12                   12; 11    15; 15     11; 11
  Max difference DBP supine -- upright 10 minutes (mean; SD)   2; 6       2; 6                    3; 6                     3; 6      4; 7       2; 6
  Max heart rate during OH test (mean; SD)                     78; 13     77; 12                  78; 11                   77; 13    79; 13     78; 13
  Change in heart rate during OH test (mean; SD)               12; 8      12; 7                   12; 11                   12; 10    12; 7      12; 8
  OH (SBP falls \>20 mmHg/DBP \>10 mmHg) (%)                   17         17                      8                        24        34         19
  Systolic OH falls \>20 mmHg (%)                              9          10                      12                       15        23         11
  Diastolic OH falls \>10 mmHg (%)                             5          6                       8                        8         10         6
  Previous or present orthostatic intolerance (%)              25         28                      35                       41        25         28
  Previous orthostatic intolerance (%)                         22         27                      31                       40        23         26
  Present orthostatic intolerance (%)                          6          5                       8                        9         8          7
  Subjective memory loss at baseline (%)                       1.6        2.4                     15.8                     6.5       5.0        11
  Objective memory loss at baseline (%)                        19.1       44.6                    24.1                     47.2      53.7       25.7

**Abbreviations:** DBP, diastolic blood pressure; GÅS-SNAC, Good Aging in Skåne; max, maximum; MCI, mild cognitive impairment; OH, orthostatic hypotension; SBP, systolic blood pressure; SD, standard deviation.

###### 

Six-year incidence of MCI and dementia at follow-up and prevalence of OH at baseline in the general elderly Swedish population of GÅS-SNAC (n=1,480)

                                               Number of persons (%)                             Mean py     Total py      6-year incidence/1,000 py   OH at baseline (%)   All persons (%)
  -------------------------------------------- ------------------------------------------------- ----------- ------------- --------------------------- -------------------- -----------------
  **Total study sample**                       1,480[a](#tfn2-cia-9-1993){ref-type="table-fn"}   5.86        8,681                                     18                   100
  **Controls (all)**                           697                                               5.87        4,092         --                          16                   47
  Men (%)/women (%)                            309 (44)/388 (56)                                 5.87/5.87   1,814/2,278   --                                               
   60--69 years (%)                            253 (47)/290 (53)                                 5.86/5.86   1,484/1,699   --                                               
   70--79 years (%)                            40 (42)/56 (58)                                   5.90/5.90   236/330       --                                               
   80+ years (%)                               16 (28)/42 (72)                                   5.91/5.93   95/249        --                                               
  **Objective memory loss (all)**              381                                               5.85        2,229         43.9                        16                   26
  Men (%)/women (%)                            201 (53)/180 (47)                                 5.83/5.86   1,172/1,055   50.9/31.4                                        
   60--69 years (%)                            145 (57)/108 (43)                                 5.83/5.86   845/633       51.7/37.4                                        
   70--79 years (%)                            37 (47)/41 (53)                                   5.83/5.84   216/239       52.8/42.9                                        
   80+ years (%)                               19 (38)/31 (62)                                   5.86/5.90   111/183       42.7/35.1                                        
  **Subjective memory loss (all)**             158                                               5.87        928           18.2                        19                   11
  Men (%)/women (%)                            51 (32)/107 (68)                                  5.83/5.89   297/630       12.9/18.7                                        
   60--69 years (%)                            32 (36)/57 (64)                                   5.83/5.82   187/332       11.4/19.7                                        
   70--79 years (%)                            13 (32)/28 (68)                                   5.93/6.00   77/168        18.6/29.3                                        
   80+ years (%)                               6 (21)/22 (79)                                    5.62/5.95   34/131        13.5/24.9                                        
  **MCI (all)**                                123                                               5.82        716           14.2                        24                   8
  Men (%)/women (%)                            64 (52)/59 (48)                                   5.74/5.90   367/348       16.2/10.3                                        
   60--69 years (%)                            34 (63)/20 (37)                                   5.80/5.92   197/118       12.1/6.9                                         
   70--79 years (%)                            12 (33)/24 (67)                                   5.62/5.80   67/139        17.1/25.1                                        
   80+ years (%)                               18 (55)/15 (45)                                   5.71/6.03   103/91        40.5/16.9                                        
  **Dementia (all)**                           121                                               5.94        719           13.9                        31                   8
  Men (%)/women (%)                            51 (42)/70 (58)                                   5.92/5.96   302/417       12.9/12.2                                        
   60--69 years (%)                            16 (47)/18 (53)                                   5.94/5.98   95/108        5.7/6.2                                          
   70--79 years (%)                            18 (58)/13 (42)                                   5.80/6.06   104/79        25.7/13.6                                        
   80+ years (%)                               17 (30)/39 (70)                                   6.02/5.91   102.3/230.5   38.2/46.2                                        
  **Any form of cognitive impairment (all)**   783                                               5.86        4,588         90.2                        20                   53
  Men (%)/women (%)                            367 (47)/416 (53)                                 5.82/5.89   2,136/2,450   92.8/72.6                                        
   60--69 years (%)                            227 (53)/203 (47)                                 5.83/5.87   1,323/1,192   80.9/70.3                                        
   70--79 years (%)                            80 (43)/106 (57)                                  5.81/5.90   465/625       114.2/111.0                                      
   80+ years (%)                               60 (36)/107 (64)                                  5.83/5.93   350/634       135.0/121.0                                      

**Note:**

In the total sample, OH tests were missing in 21 persons.

**Abbreviations:** GÅS-SNAC, Good Aging in Skåne; MCI, mild cognitive impairment; OH, orthostatic hypotension; py, person-years.

###### 

Comparisons of baseline mean values, proportions of OH test parameters, and crude and age-adjusted ORs for groups with MCI, dementia, and objective and subjective memory loss at 6-year follow-up of the general elderly Swedish population of GÅS-SNAC (n=1,480)

                                                       Controls versus objective memory loss   Controls versus subjective memory loss   Controls versus MCI   Controls versus dementia
  ---------------------------------------------------- --------------------------------------- ---------------------------------------- --------------------- --------------------------
  SBP, resting (*P*)                                   0.037                                   0.811                                    0.064                 0.435
  DBP, resting (*P*)                                   0.715                                   0.175                                    0.948                 0.316
  Quotient SBP supine/5 minutes after uprising (*P*)   0.208                                   0.205                                    0.327                 0.598
  SBP orthostatic diff max (*P*)                       0.280                                   0.777                                    0.217                 0.004
  DBP orthostatic diff max (*P*)                       0.446                                   0.600                                    0.182                 0.036
  Pulse maximum (*P*)                                  0.493                                   0.625                                    0.107                 0.843
  Pulse difference (*P*)                               0.537                                   0.365                                    0.963                 0.958
  OH, systolic or diastolic                                                                                                                                   
   OR (95% CI)                                         1.03 (0.74--1.44)                       1.27 (0.82--1.96)                        1.59 (1.00--2.50)     2.49 (1.62--3.82)
   OR, age-adjusted (95% CI)                           0.95 (0.68--1.33)                       1.07 (0.68--1.69)                        1.23 (0.75--2.00)     1.93 (1.19--3.14)
  Systolic OH                                                                                                                                                 
   OR (95% CI)                                         1.05 (0.69--1.60)                       1.33 (0.78--2.30)                        1.74 (1.00--3.03)     2.83 (1.72--4.67)
   OR, age-adjusted (95% CI)                           0.99 (0.64--1.51)                       1.12 (0.64--1.96)                        1.41 (0.79--2.53)     2.18 (1.24--3.84)
  Diastolic OH                                                                                                                                                
   OR (95% CI)                                         1.18 (0.69--2.03)                       1.64 (0.85--3.18)                        1.6 (0.77--3.32)      2.03 (1.02--4.02)
   OR, age-adjusted (95% CI)                           1.61 (0.61--1.83)                       1.32 (0.67--2.60)                        1.19 (0.55--2.55)     1.35 (0.62--2.93)
  Previous or present OI                                                                                                                                      
   OR (95% CI)                                         1.11 (0.84--1.47)                       1.55 (1.07--2.25)                        2.07 (1.39--3.08)     0.98 (0.62--1.53)
   OR, age-adjusted (95% CI)                           1.10 (0.83--1.47)                       1.55 (1.06--2.27)                        2.01 (1.33--3.05)     0.90 (0.55--1.50)
  Previous symptoms of OI                                                                                                                                     
   OR (95% CI)                                         1.26 (0.94--1.68)                       1.58 (1.08--2.32)                        2.31 (1.54--3.45)     1.01 (0.64--1.61)
   OR, age-adjusted (95% CI)                           1.26 (0.94--1.68)                       1.62 (1.10--2.40)                        2.34 (1.53--3.58)     0.99 (0.59--1.66)
  Present symptoms of OI                                                                                                                                      
   OR (95% CI)                                         0.80 (0.46--1.39)                       1.36 (0.72--2.60)                        1.47 (0.74--2.94)     1.36 (0.67--2.79)
   OR, age-adjusted (95% CI)                           0.76 (0.43--1.33)                       1.22 (0.63--2.36)                        1.26 (0.61--2.61)     0.98 (0.44--2.22)

**Abbreviations:** CI, confidence interval; DBP, diastolic blood pressure; GÅS-SNAC, Good Aging in Skåne; MCI, mild cognitive impairment; OH, orthostatic hypotension; OI, orthostatic intolerance; OR, odds ratio; orthostatic diff max, maximum difference during OH testing; SBP, systolic blood pressure.
